Literature DB >> 22424593

[Outcomes after implantation of a trifocal diffractive IOL].

G Lesieur1.   

Abstract

PURPOSE: To assess the visual and refractive outcomes after implantation of the FineVision trifocal IOL (PhysIOL, Belgium). Site: Albi, France.
METHODS: Twenty eyes of ten patients were implanted consecutively with the FineVision trifocal IOL between June and November 2010. This IOL is fully diffractive over the entire optic and presents a decrease of the diffractive step height from the center towards the periphery to improve distance vision in mesopic conditions.
RESULTS: Uncorrected binocular visual acuity was 1.00 in all cases (1.00±0.00). Near vision was equal to or better than Parinaud 2 in all cases and intermediate vision was better than Parinaud 3. The photopic defocus curve showed no decrease in the intermediate range. The visual acuity decreased by only one line at 10% contrast, which is similar to published data with bifocal IOL's.
CONCLUSION: Trifocality maintains distance and near vision performance while improving outcomes for intermediate vision. The third focal point is usable by the patient and does not create ghosting dysphotopsias.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22424593     DOI: 10.1016/j.jfo.2011.09.012

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  11 in total

1.  Objective and subjective results following implantation of the FineVision trifocal intraocular lens in Mexican patients.

Authors:  Ivo Ferreira-Ríos; Karla Zuñiga-Posselt; Juan Carlos Serna-Ojeda; Eduardo Chávez-Mondragón
Journal:  Int Ophthalmol       Date:  2017-10-12       Impact factor: 2.031

2.  Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia.

Authors:  Diego Zamora-de La Cruz; Karla Zúñiga-Posselt; John Bartlett; Mario Gutierrez; Samuel A Abariga
Journal:  Cochrane Database Syst Rev       Date:  2020-06-18

3.  Binocular function to increase visual outcome in patients implanted with a diffractive trifocal intraocular lens.

Authors:  Florian T A Kretz; Matthias Müller; Matthias Gerl; Ralf H Gerl; Gerd U Auffarth
Journal:  BMC Ophthalmol       Date:  2015-08-21       Impact factor: 2.209

4.  Visual performance after the implantation of a new trifocal intraocular lens.

Authors:  Jérôme C Vryghem; Steven Heireman
Journal:  Clin Ophthalmol       Date:  2013-10-01

5.  Visual Outcomes, Patient Satisfaction and Spectacle Independence with a Trifocal Diffractive Intraocular Lens.

Authors:  Florian Tobias Alwin Kretz; Chul Young Choi; Matthias Müller; Matthias Gerl; Ralf Helmar Gerl; Gerd Uwe Auffarth
Journal:  Korean J Ophthalmol       Date:  2016-05-18

6.  Clinical Evaluation of Functional Vision of +1.5 Diopters near Addition, Aspheric, Rotational Asymmetric Multifocal Intraocular Lens.

Authors:  Florian Tobias Alwin Kretz; Rahmin Khoramnia; Mary Safwat Attia; Michael Janusz Koss; Katharina Linz; Gerd Uwe Auffarth
Journal:  Korean J Ophthalmol       Date:  2016-09-29

7.  Comparison of Reading Speed after Bilateral Bifocal and Trifocal Intraocular Lens Implantation.

Authors:  Moses Kim; Jae Hyung Kim; Tae Hyung Lim; Beom Jin Cho
Journal:  Korean J Ophthalmol       Date:  2018-03-19

8.  Visual outcomes and patient satisfaction after bilateral implantation of a new trifocal diffractive intraocular lens.

Authors:  Abdulmohsen K Almulhim; Khalid M Alarfaj; Abdulaziz A Altaisan; Arwa Z Alromaih; Razan A Aldawod
Journal:  Saudi J Ophthalmol       Date:  2018-09-17

9.  Clinical Outcomes after Binocular Implantation of a New Trifocal Diffractive Intraocular Lens.

Authors:  Florian T A Kretz; Detlev Breyer; Vasilios F Diakonis; Karsten Klabe; Franziska Henke; Gerd U Auffarth; Hakan Kaymak
Journal:  J Ophthalmol       Date:  2015-08-02       Impact factor: 1.909

10.  Effect of incision on visual outcomes after implantation of a trifocal diffractive IOL.

Authors:  Shasha Xue; Guiqiu Zhao; Xiaoni Yin; Jing Lin; Cui Li; Liting Hu; Lin Leng; Xuejiao Yang
Journal:  BMC Ophthalmol       Date:  2018-07-13       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.